1.44
Indivior Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
1.26
FY23:
1.26
FY24:
0.83
FY25:
0.65
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.39
FY22:
0.51
FY23:
0.50
FY24:
0.49
FY25:
0.55
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.83
FY22:
1.77
FY23:
1.76
FY24:
1.32
FY25:
1.20
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.80
FY22:
1.02
FY23:
1.28
FY24:
0.92
FY25:
0.91
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.83
FY22:
0.70
FY23:
0.66
FY24:
0.73
FY25:
0.39
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.20
FY22:
0.05
FY23:
−0.18
FY24:
−0.34
FY25:
−0.10
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.83
FY22:
1.77
FY23:
1.76
FY24:
1.32
FY25:
1.20
All amounts in billions USD